Keywords: teva, invests, 1m, israel, cellcure, neurosci, world

Teva invests $1M in Israel's Cellcure Neurosci

Article | 10 September 2007

World generic giant Teva Pharmaceutical Industries is investing $1.0 million in tissue technology startup Cellcure Neurosciences, a stem cell therapy company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Teva Pharmaceutical Industries

Go to company listing

Related Drugs

Azilect

Rasagiline

Go to drug listing